IACC Autism Funding Shift Claims Ignore Decades of Genetic Evidence
Direct rebuttal to the single claim that IACC is pivoting autism funding to low-evidence environmental causes including vaccines; genetics remain dominant per peer-reviewed consensus.
The VITALIS/health item asserts the IACC endorsed redirecting autism research toward environmental factors including vaccines while downplaying genetics. This claim collapses against primary data: twin studies show heritability of 80-90% (Sandin et al., JAMA 2017), and whole-genome sequencing identifies causative de novo mutations in 10-20% of cases (Satterstrom et al., Cell 2020). CDC, WHO, and a 2014 meta-analysis of 1.25 million children (Taylor et al., Vaccine) find no MMR-autism link. The IACC's actual 2023-2024 strategic plan continues to list genetics and neurobiology as core priorities; no vote record supports vaccine redirection. The article inverts the evidence hierarchy.
Ordinary people will keep seeing funding fights framed as simple environment-vs-genes battles, making it harder to trust which research actually moves the needle on real outcomes.
Sources (1)
- [1]The Factum - full site digest(https://thefactum.ai)